These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33490093)

  • 1. Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies.
    Li X; Wu S; Yu Y
    Front Med (Lausanne); 2020; 7():569759. PubMed ID: 33490093
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis.
    Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L
    BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinfection of
    Madala S; MacDougall K; Surapaneni BK; Park R; Girotra M; Kasi A
    J Clin Med Res; 2021 Dec; 13(12):530-540. PubMed ID: 35059071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population.
    Li L; Lan X
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C284-C287. PubMed ID: 28230038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis.
    Li X; Yu Y; Liu L
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101545. PubMed ID: 33067170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
    JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.
    Liao YH; Hsu RJ; Wang TH; Wu CT; Huang SY; Hsu CY; Su YC; Hsu WL; Liu DW
    BMC Gastroenterol; 2020 Jan; 20(1):6. PubMed ID: 31918672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
    Luo X; Wang Y; Shen A; Deng H; Ye M
    BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
    Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
    Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
    Chang FM; Wang YP; Lang HC; Tsai CF; Hou MC; Lee FY; Lu CL
    Hepatology; 2017 Sep; 66(3):896-907. PubMed ID: 28318053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
    Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
    Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
    Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
    J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis.
    Benvegnù L; Alberti A
    Antiviral Res; 2001 Nov; 52(2):199-207. PubMed ID: 11672830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma.
    Zhang Y; Zhu SL; Chen J; Li LQ
    Onco Targets Ther; 2016; 9():3249-57. PubMed ID: 27313470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of serum hepatitis B virus load in the carcinogenesis and prognosis of hepatocellular carcinoma: evidence from two meta-analyses.
    Chen X; Wu F; Liu Y; Lou J; Zhu B; Zou L; Chen W; Gong J; Wang Y; Zhong R
    Oncotarget; 2016 Aug; 7(31):49299-49309. PubMed ID: 27384478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.